Transgenic Mice to Study the Role of Dopamine Receptors in Cardiovascular Function

References

• Jose P. A., Eisner G. M., Drago J., Carey R. M., Felder R. A. Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens. 1996; 9: 400–405
   PubMed Web of Science ®Google Scholar
• Jose P. A., Raymond J. R., Bates M. D., Aperia A., Felder R. A., Carey R. M. The renal dopamine receptors. J Am Soc Nephrol. 1992; 2: 1265–1278
   PubMed Web of Science ®Google Scholar
• Ball S. G., Lee M. R. The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br J Clin Pharmacol. 1977; 4: 115–119
   PubMed Web of Science ®Google Scholar
• Hegde S. S., Jadhav A. L., Lokhandwala M. F. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 1989; 13: 828–834
   PubMed Web of Science ®Google Scholar
• Siragy H. M., Felder R. A., Howell N. L., Chevalier R. L., Peach M. J., Carey R. M. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol. 1989; 257: F469–F477
   PubMed Web of Science ®Google Scholar
• Hansell P., Fasching A. The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int. 1981; 39: 253–258
   Google Scholar
• Mülhlbauer B., Osswald H. Urinary dopamine excretion in conscious rats: effects of carbidopa in different states of sodium balance. Renal Physiol. Biochem. 1993; 16: 117–124
   PubMedGoogle Scholar
• Pelayo J. C., Fildes R. D., Eisner G. M., Jose P. A. Effects of dopamine blockade on renal sodium excretion. Am J Physiol. 1983; 245: F247–F253
   PubMed Web of Science ®Google Scholar
• Goldstein D. S., Stull R., Eisenhofer G., Gill J. R., Jr. Urinary excretion of dihydroxy-phenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci. 1989; 76: 517–522
   PubMed Web of Science ®Google Scholar
• Bertorello A., Hokfelt T, Goldstein T., Aperia A. Proximal tubule Na+-K+ ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol. 1988; 254: F795–F801
   PubMed Web of Science ®Google Scholar
• Felder R. A., Seikaly M. G., Cody P., Eisner G. M., Jose P. A. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 1990; 15: 560–569
   PubMed Web of Science ®Google Scholar
• Nishi A., Eklöf A C., Bertorello A. M., Aperia A. Dopamine regulation of renal Na+, K+-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993; 21: 767–771
   PubMed Web of Science ®Google Scholar
• Debska-Slizien A., Ho P., Drangova R., Baines A. D. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol. 1994; 5: 1125–1132
   PubMed Web of Science ®Google Scholar
• Chen C. J., Beach R. E., Lokhandwala M. F. Dopamine fails to inhibit renal tubular sodium pump in spontaneously hypertensive rats. Hypertension 1993; 21: 364–372
   PubMed Web of Science ®Google Scholar
• Gesek F. A., Schoolwerth A. C. Hormone responses of proximal Na+-H− exchanger in spontaneously hypertensive rats. Am J Physiol. 1991; 261: F526–F536
   PubMed Web of Science ®Google Scholar
• Gurich R. W., Beach R. E. Abnormal regulation of renal proximal tubule Na+-K+-ATPase by G proteins in spontaneously hypertensive rats. Am J Physiol. 1994; 267: F1069–F1075
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Sidhu A, Felder R A. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84: 1849–1856
   PubMed Web of Science ®Google Scholar
• Felder R. A., Kinoshita S., Ohbu K., Mouradian M. M., Sibley D. R., Monsma F. J., Jr., Minowa T., Minowa M. T., Canessa L. M., Jose P. A. Renal dopamine-1 receptor mRNA and organ specificity of the dopamine-1 receptor/adenylyl cyclase coupling defect in the spontaneously hypertensive rat. Am J Physiol. 1993; 264: R726–R732
   PubMed Web of Science ®Google Scholar
• Horiuchi A., Albrecht F., Eisner G. M., Jose P. A., Felder R. A. Renal dopamine receptors and pre- and post-cAMP mediated sodium transport defect in the spontaneously hypertensive rat. Am J Physiol. 1992; 263: F1105–F1111
   PubMed Web of Science ®Google Scholar
• Chen C. J., Vyas S. J., Eichberg J., Lokhandwala M. F. Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats. Hypertension 1992; 19: 102–108
   PubMed Web of Science ®Google Scholar
• Chatziantoniou C., Ruan X., Arendshorst W. J. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 1995; 92: 2924–2928
   PubMed Web of Science ®Google Scholar
• Racz K., Kuchel O., Buu N. T., Tenneson S. Peripheral dopamine synthesis and metabolism in spontaneously hypertensive rats. Circ Res. 1986; 57: 889–897
   Web of Science ®Google Scholar
• Albrecht F E., Robillard J. E., Eisner G. M., Jose P. A. Receptor and G-protein regulation of the renal apical sodium/hydrogen exchanger (NHE) in genetic hypertension. Pediatr Res. 1995; 37: 358A, (Abstract).
   Web of Science ®Google Scholar
• Shigetomi S., Ueno S., Kono H., Tosaki H., Suenaga K., Hashimoto S., Fukuchi S. Role of dopamine receptor in the pathogenesis of hypertension after sodium loading. Folia Endocrinol. 1986; 62: 26–33
   Google Scholar
• Yoshirnura M., Kambara S., Takahashi H., Okabayashi H., Ijichi H. Involvement of dopamine in the development of hypertension in spontaneously hypertensive rats; effect of carbidopa, inhibitor of peripheral dopa decarboxylase. Clin Exp Hypertens. 1987; A: 1585–1599
   Google Scholar
• Albrecht F E, Drago J., Felder R. A., Print. M. R., Eisner G. M., Robillard J. E., Sibley D. R., Westphal H., Jose P. A. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996; 97: 2283–2288
   PubMed Web of Science ®Google Scholar
• Burgess L. H., Monsma F. J., Jr., Shen Y., Jose P. A., Sibley D. R. Further characterization of D_1A and D_1B dopamine receptors in rat kidney. Soc Neurosci Abstracts, Washington, DC 1993; 75
   Google Scholar
• Matsushima Y., Kawamura M., Akabane S., Imanishi M., Kuramochi M., Ito K., Omae T. Increases in angiotensin II content and tubular angiotensin II receptors in pre-hypertensive spontaneously hypertensive rat. J Hypertens. 1988; 6: 791–796
   PubMed Web of Science ®Google Scholar
• Thomas D., Harris P. J., Morgan T. O. Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat. J Hypertens 1988; 6((suppl 4))S449–S451.
   Google Scholar
• Cheng H F., Becker B. N., Harris R. C. Dopamine decreases expression of type 1 angiotensin II (AT1 R) receptor expression in the proximal tubule. J Am Soc Nephrol. 1995; 6: 734, (Abstract).
   Web of Science ®Google Scholar
• Siragy H. M., Felder R. A., Howell N. L., Chevalier N. L., Peach M. J., Carey R. M. Evidence that dopamine-2 mechanisms control renal function. Am J Physiol. 1990; 259: F793–F800
   PubMed Web of Science ®Google Scholar
• Bertorello A., Aperia A. Inhibition of proximal tubule Na+-K+-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol. 1990; 259: F924–F928
   PubMed Web of Science ®Google Scholar
• Satoh T., Cohen H. T., Katz A. I. Intracellular signaling in the regulation of renal Na-K-ATPase1. Role of cyclic AMP and phospholipase A₂. J Clin Invest. 1992; 89: 1496–1500
   PubMed Web of Science ®Google Scholar
• Sheikh-Hamad D., Wang Y. P., Jo O. D., Yanagawa N. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol. 1993; 264: F737–F743
   PubMed Web of Science ®Google Scholar
• Oparil S., Chen Y F., Berecek K. H., Calhoun D. A., Wyss J. M. The role of the central nervous system in hypertension. Hypertension, Pathophysiology, Diagnosis, and Management, 2nd edition, J. H. Laragh, B. M. Brenner. Raven Press, NY 1995; 713–740
   Google Scholar
• Koepke J. P., Kopp U. C., DiBona G. F. The kidney in the pathogenesis of hypertension: role of the renal nerves. The Kidney in Hypertension, N. M. Kaplan, B. M. Brenner, J. H. Laragh. Raven Press, NY 1987; 53–65
   Google Scholar
• Essler M., Ferrier C., Lambert G., Eisenhofer G., Cox H., Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension 1991; 17(supplII)III-29–III-35.
   Google Scholar
• Lundin S., Ricksten S. E., Thoren P. Renal sympathetic activity in spontaneously hyper-tensive rats and normotensive controls, studied by three different methods. Acta Physiol Scand. 1984; 120: 265–272
   PubMedGoogle Scholar
• Petrovic T., Bell C. Catecholamines in kidneys of normotensive and genetically hypertensive ratsEffects of salt load. Hypertension 1986; 8: 122–127
   PubMed Web of Science ®Google Scholar
• Adams M. A., Bobik A., Korner P I. Differential development of vascular and cardiac hypertrophy in genetic hypertensionRelation to sympathetic function. Hypertension 1989; 14: 191–202
   PubMed Web of Science ®Google Scholar
• Yoshida M., Yoshida W., Satoh S. Effect of renal denervation on tissue catecholamine content in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1995; 22: 512–517
   PubMed Web of Science ®Google Scholar
• Cooper J. R., Bloom F E, Roth R. H. The Biochemical Basis of Neuropharmacology. 6th ed. Oxford University Press, NY 1991
   Google Scholar
• Rump L. C., Schollmeyer P. J. Dopamine modulation of neurotransmission in rat and human kidney. Cardiovascular and Renal Actions of Dopamine, P. Soares-Da-Silva. Pergamon Press, Oxford, England 1993; 91–98.
   Google Scholar
• Bohmann C., Rump L. C., Schaible U., von Kugelgen I. Alpha-adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension 1995; 25: 1224–1231.
   PubMed Web of Science ®Google Scholar
• Bohmann C., Schaible U., Schollmeyer P., Rump L. C. Alpha2D-adrenoceptors modulate renal noradrenaline release in normotensive and spontaneously hypertensive rats. Eur J Pharmacol. 1994; 271: 283–292
   PubMed Web of Science ®Google Scholar
• Tsuda K., Tsuda S., Masuyama Y. The role of dopamine in the regulation of neuro-transmitter release in spontaneously hypertensive rats. Jpn Heart J. 1988; 29: 215–222
   PubMedGoogle Scholar
• Goldberg L. I., Kohli J. D., Glock D. Conclusive evidence for two subtypes of peripheral dopamine receptors. Dopaminergic Systems and Their Regulation, G. N. Woodruff, J. A. Poat, P. J. Roberts. Macmillan, London 1986; 195–212.
   Google Scholar
• Lokhandwala M. F., Steenberg M. L. Selective activation by LY-141865 and apomor-phine of presynaptic dopamine receptors in the rat kidney and influence of stimulation of parameters in the action of dopamine. J Pharmacol Exp Ther. 1984; 228: 161–167
   PubMed Web of Science ®Google Scholar
• Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., Schwartz J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (Lond) 1990; 347: 146–151
   PubMed Web of Science ®Google Scholar
• Gobert A., Rivet J M., Audinot V., Cistarelli L., Spedding M., Vian J., Pedglion J L., Millan M. J. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: IIBoth D2 and “silent” D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J Pharmacol Exp Ther. 1995; 275: 899–913
   PubMed Web of Science ®Google Scholar
• Mierau J., Schneider F. J., Ensinger H. A., Chio C. L., Lajiness M. E., Huff R. M. Pramipexole binding and activation of clone and expressed D2, D3 and D4 receptors. Eur J Pharmacol. 1995; 290: 29–36
   PubMed Web of Science ®Google Scholar
• Gao D Q., Canessa L. M., Mouradian M. M., Jose P. A. Expression of the D2 subfamily of dopamine receptor genes in the kidney. Am J Physiol. 1994; 266: F646–F650
   PubMed Web of Science ®Google Scholar
• O'Malley K. L., Harmon S., Tang L., Han S., Todd R. D. The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 1992; 4: 137–146
   PubMedGoogle Scholar
• Henrich W. L., Levi M. Ontogeny of renal renin release in spontaneously hypertensive rat and Wistar-Kyoto rat. Am J Physiol. 1991; 260: F530–F535
   PubMed Web of Science ®Google Scholar
• Yao L., Yamaguchi I., Ozono R., Walk S. F., McGrath B., Dagli H., Carey R. M., Jose P. A., Felder R. A. Dopamine receptor (DAR) subtype expression and function in rat juxtaglomerular (JG) cells. Pediatr Res. 1996; 39: 372A.
   Google Scholar
• Worth D. P., Harvey J. N., Brown J., Worral A., Lee M. R. Domperi-done treatment in man inhibits the fall in plasma renin activity induced by intravenous y-L-glutamyl-L-dopa. Br J Clin Pharmacol. 1986; 21: 497–502
   PubMed Web of Science ®Google Scholar
• MacDonald T. M., Jeffrey R. F., Freestone S., Lee M. R. (+)-sulpiride antagonizes the renal effects of gamma-L-glutamyl-L-dopa in man. Br J Clin Pharmacol. 1988; 25: 203–212
   PubMed Web of Science ®Google Scholar